Hospital
Mercy Health - Anderson Hospital LLC
Mercy Health - Anderson Hospital LLC was paid $11.07M by Medicaid between Jan 2018 and Dec 2024, across 215 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoMERCY HEALTH - ANDERSON HOSPITAL LLC
CINCINNATI, OH 45255
CINCINNATI, OH 45255
33aNPI1235239211assigned 09/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.07M
24GClaims351,665
24DCodes billed215
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#73 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,365 | $1.34M | |
| 2019 | 29,172 | $1.02M | |
| 2020 | 20,937 | $756K | |
| 2021 | 14,159 | $621K | |
| 2022 | 16,960 | $649K | |
| 2023 | 136,466 | $3.87M | |
| 2024incomplete | 94,606 | $2.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 19,250 | 17,900 | $2.13M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 17,807 | 15,855 | $2.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 9,928 | 8,311 | $1.28M |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.6% | 4,659 | 3,626 | $951K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.1% | 2,769 | 2,310 | $675K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.4% | 1,877 | 1,559 | $371K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 6,599 | 2,009 | $290K |
| G0378 | Hospital observation service, per hour | 2.5% | 4,239 | 1,591 | $278K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 2,531 | 2,377 | $229K |
| 80053 | Comprehensive metabolic panel | 1.8% | 30,851 | 26,733 | $203K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 785 | 632 | $188K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.5% | 3,755 | 1,137 | $170K |
203 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,669 | $169K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.5% | 1,052 | $169K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.4% | 1,574 | $150K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.3% | 1,004 | $147K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 748 | $138K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.1% | 331 | $116K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 240 | $85K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,152 | $80K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 716 | $60K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 448 | $58K |
| 70496 | <1% | 265 | $50K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,707 | $48K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,515 | $43K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,348 | $41K |
| 84484 | <1% | 11,003 | $37K | |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 377 | $34K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,585 | $32K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 732 | $32K |
| 97161 | <1% | 999 | $30K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 199 | $30K |
| 94060 | <1% | 250 | $27K | |
| 71250 | <1% | 327 | $26K | |
| 93017 | <1% | 369 | $26K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 33,076 | $25K |
| 93971 | <1% | 310 | $22K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,921 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,444 | $22K |
| 80061 | Lipid panel | <1% | 1,577 | $21K |
| 86900 | <1% | 1,080 | $18K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 34 | $16K |
| 76830 | Ultrasound, transvaginal | <1% | 325 | $15K |
| 72100 | <1% | 411 | $15K | |
| 94726 | <1% | 287 | $15K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,085 | $14K |
| 94729 | <1% | 294 | $14K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 108 | $13K |
| 97116 | <1% | 696 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,064 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,020 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,804 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,883 | $11K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $10K |
| 76801 | <1% | 133 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,220 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,714 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,796 | $9K |
| 71271 | <1% | 58 | $9K | |
| 93458 | <1% | 21 | $9K | |
| 97162 | <1% | 451 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 556 | $8K |
| 86850 | <1% | 810 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 723 | $7K |
| 73630 | <1% | 494 | $7K | |
| 73030 | <1% | 438 | $7K | |
| 73560 | <1% | 424 | $6K | |
| 83880 | <1% | 1,844 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 275 | $5K |
| 73610 | <1% | 466 | $5K | |
| 73130 | <1% | 301 | $5K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 85 | $5K |
| 85027 | <1% | 1,970 | $4K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 272 | $4K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 144 | $4K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 17 | $4K |
| 97166 | <1% | 202 | $4K | |
| 85610 | <1% | 2,035 | $4K | |
| 74018 | <1% | 152 | $4K | |
| 88307 | <1% | 35 | $4K | |
| 83735 | <1% | 3,249 | $4K | |
| 76642 | <1% | 31 | $4K | |
| 70498 | <1% | 273 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 51 | $3K |
| 84702 | <1% | 1,014 | $3K | |
| 81001 | <1% | 8,428 | $3K | |
| 84703 | <1% | 8,063 | $3K | |
| 82607 | <1% | 206 | $3K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,306 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $3K |
| 96376 | <1% | 1,478 | $3K | |
| 82570 | <1% | 435 | $3K | |
| 80076 | <1% | 413 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 569 | $3K |
| 73110 | <1% | 187 | $2K | |
| 82565 | <1% | 381 | $2K | |
| 86140 | <1% | 442 | $2K | |
| 90715 | <1% | 141 | $2K | |
| 73502 | <1% | 180 | $2K | |
| 83690 | <1% | 6,216 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 45 | $2K |
| 83605 | <1% | 2,308 | $2K | |
| 86701 | <1% | 65 | $2K | |
| 84439 | <1% | 126 | $2K | |
| 81003 | <1% | 4,022 | $2K | |
| 86803 | <1% | 103 | $2K | |
| 83550 | <1% | 178 | $2K | |
| J3490 | Unclassified drugs | <1% | 75 | $2K |
| 80069 | <1% | 151 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 568 | $2K |
| 96367 | <1% | 100 | $2K | |
| 86901 | <1% | 1,078 | $1K | |
| 97165 | <1% | 28 | $1K | |
| 82077 | <1% | 693 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,865 | $1K |
| 83540 | <1% | 195 | $1K | |
| 87390 | <1% | 63 | $1K | |
| 00731 | <1% | 236 | $1K | |
| 97014 | <1% | 29 | $1K | |
| 85652 | <1% | 354 | $1K | |
| 97016 | <1% | 30 | $992.74 | |
| 73562 | <1% | 49 | $952.97 | |
| 86702 | <1% | 63 | $952.25 | |
| 85730 | <1% | 338 | $860.99 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $795.58 |
| 82746 | <1% | 117 | $790.90 | |
| 87081 | <1% | 520 | $760.74 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 79 | $747.22 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,721 | $743.69 |
| 93880 | <1% | 12 | $704.85 | |
| 85379 | <1% | 1,097 | $669.25 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,689 | $651.77 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,812 | $572.06 |
| 82803 | <1% | 941 | $565.43 | |
| 87186 | <1% | 468 | $462.05 | |
| 87040 | <1% | 872 | $422.64 | |
| 87077 | <1% | 503 | $416.16 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,256 | $415.23 |
| 87210 | <1% | 349 | $374.24 | |
| 82728 | <1% | 37 | $373.23 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 612 | $357.12 |
| C1769 | Guide wire | <1% | 563 | $355.21 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,737 | $315.05 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 142 | $262.79 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,580 | $254.68 |
| 82550 | <1% | 128 | $225.80 | |
| 84156 | <1% | 101 | $217.21 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,686 | $216.39 |
| 94761 | <1% | 295 | $214.13 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,142 | $197.93 |
| 99152 | <1% | 61 | $197.76 | |
| 73590 | <1% | 19 | $192.74 | |
| 84550 | <1% | 81 | $192.18 | |
| J2704 | Injection, propofol, 10 mg | <1% | 4,905 | $190.73 |
| 94150 | <1% | 13 | $164.28 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 483 | $156.07 |
| 84100 | <1% | 58 | $102.18 | |
| 87807 | <1% | 130 | $98.50 | |
| 94664 | <1% | 15 | $96.14 | |
| 72040 | <1% | 15 | $94.24 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 413 | $85.47 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,452 | $83.06 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 949 | $75.22 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 146 | $74.56 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 791 | $70.58 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 455 | $70.50 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 407 | $66.23 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 496 | $64.95 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 144 | $64.33 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 612 | $62.02 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 400 | $59.43 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,081 | $49.45 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 262 | $47.48 |
| 80143 | <1% | 58 | $46.33 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,292 | $43.69 |
| 84145 | <1% | 149 | $42.28 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,070 | $40.18 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 283 | $39.47 |
| 85014 | <1% | 22 | $38.98 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 31 | $26.80 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 322 | $25.68 |
| 85018 | <1% | 17 | $23.36 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,877 | $22.47 |
| 84132 | <1% | 15 | $18.60 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 391 | $16.36 |
| 87088 | <1% | 17 | $15.65 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 58 | $14.59 |
| 82270 | <1% | 16 | $12.71 | |
| 83615 | <1% | 15 | $12.69 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 94 | $12.30 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 71 | $6.97 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 99 | $5.28 |
| J0687 | Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg | <1% | 59 | $4.37 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 678 | $4.00 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 136 | $2.73 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 101 | $2.02 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 13 | $1.82 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 70 | $0.60 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 69 | $0.53 |
| C9399 | Unclassified drugs or biologicals | 0% | 79 | $0.00 |
| 94760 | 0% | 142 | $0.00 | |
| 88304 | 0% | 355 | $0.00 | |
| 88342 | 0% | 55 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 26 | $0.00 |
| J2305 | Injection, nitroglycerin, 5 mg | 0% | 17 | $0.00 |
| 51798 | 0% | 22 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 120 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 209 | $0.00 |
| 80179 | 0% | 15 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 61 | $0.00 |
| 01810 | 0% | 28 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 42 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 13 | $0.00 |
| 00812 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJAMES, KENNETH (PRESIDENT MERCY HEALTH ANDERSON)
| Provider | Location | Paid |
|---|---|---|
| Trade Masters INC | Youngstown, OH | $327K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.